Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Cerus Corporation

< Previous 1 2 3 Next >
Cerus Corporation Announces First Quarter 2024 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Third Quarter 2023 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Second Quarter 2023 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Celebrates World Blood Donor Day 2023
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces First Quarter 2023 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Participate in Upcoming Investor Conferences
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Third Quarter Financial Results
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage
From Cerus Corporation
Via Business Wire
Tickers CERS
Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022
From Cerus Corporation
Via Business Wire
Tickers CERS
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.